These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 18990502)

  • 1. Gentamicin-induced deafness may be reversed by restarting cell cycle.
    Han Y; Qiu J; Qiao L; Zhong C
    Med Hypotheses; 2009 Mar; 72(3):368-9. PubMed ID: 18990502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deafness and equilibrium disorders caused by gentamicin].
    Huizing EH
    Ned Tijdschr Geneeskd; 1972 Jul; 116(30):1261-4. PubMed ID: 5041294
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Hearing loss due to gentamicin therapy.
    Huizing EH; Carrière
    ORL J Otorhinolaryngol Relat Spec; 1975; 37(6):359-60. PubMed ID: 1239710
    [No Abstract]   [Full Text] [Related]  

  • 4. Ototoxicity: neomycin or gentamicin?
    Levay ID
    Clin Pharm; 1982; 1(6):497-8. PubMed ID: 7185538
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gentamicin and deafness].
    Conde Jahn F
    Acta Otorinolaryngol Iber Am; 1973; 24(2):106-8. PubMed ID: 4803643
    [No Abstract]   [Full Text] [Related]  

  • 6. Gentamicin ear drops and ototoxicity: update.
    Stockwell M
    CMAJ; 2001 Jan; 164(1):93-4, 97-8. PubMed ID: 11202681
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of gentamicin accentuated hearing loss.
    Stephens SD
    J Laryngol Otol; 1968 Sep; 82(9):803-8. PubMed ID: 5681139
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
    Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
    Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A; Bozko P; Sabisz M
    Chem Rev; 2009 Jul; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats.
    Li J; Li QX; Xie XF; Ao Y; Tie CR; Song RJ
    Eur J Pharmacol; 2009 Oct; 620(1-3):97-104. PubMed ID: 19698708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
    Medendorp K; van Groningen JJ; Vreede L; Hetterschijt L; Brugmans L; van den Hurk WH; van Kessel AG
    Exp Cell Res; 2009 Aug; 315(14):2399-409. PubMed ID: 19422821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of dehydrocostuslactone through cell cycle arrest and apoptosis in human ovarian cancer SK-OV-3 cells.
    Choi EJ; Ahn WS
    Int J Mol Med; 2009 Feb; 23(2):211-6. PubMed ID: 19148545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TgI4 lipase: a big fat target for cell-cycle entry.
    Futcher B
    Mol Cell; 2009 Jan; 33(2):143-4. PubMed ID: 19187756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential toxic effects of methyl tertiary butyl ether and tert-butanol on rat fibroblasts in vitro.
    Sgambato A; Iavicoli I; De Paola B; Bianchino G; Boninsegna A; Bergamaschi A; Pietroiusti A; Cittadini A
    Toxicol Ind Health; 2009 Mar; 25(2):141-51. PubMed ID: 19458137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnapShot: Cell-cycle regulators II.
    Morgan DO
    Cell; 2008 Nov; 135(5):974-974.e1. PubMed ID: 19041757
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the inhibitory mechanism of D-allose on MOLT-4F leukemia cell proliferation.
    Hirata Y; Saito M; Tsukamoto I; Yamaguchi F; Sui L; Kamitori K; Dong Y; Uehara E; Konishi R; Janjua N; Tokuda M
    J Biosci Bioeng; 2009 May; 107(5):562-8. PubMed ID: 19393559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
    Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
    Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Fluoro-N-butylphenylacetamide (H6) inhibits cell growth via cell-cycle arrest and apoptosis in human cervical cancer cells.
    Liu CH; Huang LJ; Kuo SC; Lee TH; Tsai KJ; Chan HC
    Bioorg Med Chem; 2009 Jan; 17(1):42-8. PubMed ID: 19056280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells.
    Liu L; Choi JH; Yim H; Choi JS; Park BD; Cho SJ; Lee SK
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1410-20. PubMed ID: 19154794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
    Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
    Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.